… a Phase 1b safety, tolerability and exploratory efficacy trial. Top-line data to be reported in mid-2017 Top-line data from a previous clinicaltrial demonstrated that QR-010 restores CFTR …
… has started in study PQ-010-001, a global Phase 1b clinical study of QR-010, a novel investigational RNA … of CF. We are very pleased to participate in the first clinicaltrial for this novel compound," said Professor Stuart Elborn …
… ProQR Announces Clinical Data Presentations and Investor & Analyst Event at … from the nasal potential difference (NPD) proof of concept clinicaltrial (PQ-010-002) of lead program, QR-010, in subjects with …